Key result
Concordant CMR and FDG PET/CT in myocarditis linked to ~261% higher major cardiovascular events risk vs discordant findings.
Why the study?
The role of FDG PET/CT in known or suspected myocarditis and its prognostic value in addition to CMR remains unknown.
Do concordant FDG PET/CT and CMR findings predict major adverse cardiovascular events in patients with known or suspected myocarditis?
Cohort (n=100)
No
Do concordant FDG PET/CT and CMR findings predict major adverse cardiovascular events in patients with known or suspected myocarditis?
Concordant findings of focal LGE on CMR and FDG uptake on PET/CT are associated with a significantly increased risk of major adverse cardiovascular events at one year in patients with known or suspected myocarditis.
Answers are grounded in this paper and cite their sources.
Concordant FDG PET/CT and CMR findings may refine myocarditis risk stratification; hypothesis-generating and requires prospective validation before guiding decisions.
INTRODUCTION: Cardiac magnetic resonance imaging (CMR) is a powerful tool in evaluating myocarditis. The role of fluorodeoxyglucose-positron emission tomography/computed tomography (FDG PET/CT) in known or suspected myocarditis remains unknown. We aimed to investigate whether FDG PET/CT adds prognostic value to CMR in patients with known or suspected myocarditis. METHODS: From a registry of 1,646 patients at Brigham and Women's Hospital who underwent FDG PET/CT for known or suspected inflammatory cardiomyopathy, we applied the following criteria: 1) had a primary clinical diagnosis of myocarditis, including focal late gadolinium enhancement suggestive of myocarditis on CMR, 2) underwent both FDG PET/CT and CMR within 12 months, and 3) had no evidence of cardiac or extracardiac sarcoidosis via histology or metabolically active extracardiac sarcoidosis via FDG PET/CT. Imaging findings were categorized as 1)'concordant' if there was at-least one matched myocardial segment with focal LGE on CMR and FDG uptake on PET/CT or 2) 'discordant' if there were no matched segments. The primary outcome was major adverse cardiovascular event (MACE), a composite of heart failure hospitalization, sustained ventricular tachycardia (VT)/ventricular fibrillation, VT ablation, left ventricular assist device placement, cardiac transplant, and death at one-year. RESULTS: We identified 100 patients (59±13 years, 74% male, LVEF 51±13%) who met inclusion criteria. Concordant imaging findings were present in 45 patients (61±11, 73% male, LVEF 50±13%) and discordant in 55 (57±15, 75% male, LVEF 52±13%). Patients in the concordant group were most likely to be treated with immunosuppression after imaging than the discordant group (31% vs 9.1% p=0.005). In an adjusted model, patients with concordant imaging findings had a higher risk of MACE than patients with discordant imaging findings (aHR: 3.61 [95% CI: 1.14, 11.39], p=0.028). CONCLUSION: FDG PET/CT may have prognostic value in select patients with known or suspected myocarditis as patients in our study with concordant CMR and FDG PET/CT findings were at increased risk of MACE in follow-up.
No takes yet. Share an insight, caveat, or question.
Rojulpote et al. (2026) conducted a cohort in Known or suspected myocarditis (n=100). Concordant CMR and FDG PET/CT imaging findings vs. Discordant imaging findings was evaluated on Major adverse cardiovascular event (MACE), a composite of heart failure hospitalization, sustained ventricular tachycardia/fibrillation, VT ablation, LVAD placement, cardiac transplant, and death at one-year (aHR 3.61, 95% CI 1.14-11.39, p=0.028). Concordant CMR and FDG PET/CT findings in myocarditis patients were associated with a higher risk of major cardiovascular events at one year compared to discordant findings.
Synapse has enriched 10 related papers. Consider them for comparative context: